Finanical Statements
Alexandria Pharmaceuticals (AXPH.CA) Reports 3 Months Results
Published at 15 November 2026 at 13:16 Cairo timeAlexandria PharmaceuticalsRelated stock:Alexandria Pharmaceuticals stockAll Alexandria Pharmaceuticals disclosures
Disclosure summary
Company Name : Alexandria Pharmaceuticals
ISIN Code : EGS38341C011
Currency : EGP
F/S Period : From 01/07/2026 To 30/09/2026
Net Profit : 133,501,244
F/S Period: From 01/07/2025 To 30/09/2025
Net Comparative Profit : 103,736,529
Audit Status : Reviewed
Source : Alexandria Pharmaceuticals
The Financial Statements in Arabic & English (5,118 KB)
ISIN Code : EGS38341C011
Currency : EGP
F/S Period : From 01/07/2026 To 30/09/2026
Net Profit : 133,501,244
F/S Period: From 01/07/2025 To 30/09/2025
Net Comparative Profit : 103,736,529
Audit Status : Reviewed
Source : Alexandria Pharmaceuticals
The Financial Statements in Arabic & English (5,118 KB)